Entrada Therapeutics TRDA
NASDAQ TRDA
$6.30 +0.04 (+0.64%)
As of: Sep 30, 2026 · 12:23 PM EDT

Entrada Therapeutics, Inc. (TRDA) Tax Provisions (2023 - 2026)

Updated

Entrada Therapeutics' Tax Provisions came in at $35,000 for Q2 2026, down 80.3% from $178,000 a year earlier and down 7.9% from the prior quarter.

Analysis

Entrada Therapeutics, Inc. (TRDA) Tax Provisions (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Entrada Therapeutics reported Tax Provisions of $865,000; for FY2025, it came in at $924,000, up 2.7% from FY2024.

  • Going back by year, Tax Provisions was $900,000 in FY2024 (-95.2%) and $18.74 million in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Tax Provisions since Q4 2024.
  • Business Quant data shows TRDA's Tax Provisions at $38,000 (Q1 2026), $92,000 (Q4 2025) and $700,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35,000.00
Mar 31, 2026 38,000.00
Dec 31, 2025 92,000.00
Sep 30, 2025 700,000.00
Jun 30, 2025 178,000.00
Dec 31, 2024 -1.83 Mn
Sep 30, 2024 -1.90 Mn
Jun 30, 2024 2.80 Mn
Mar 31, 2024 1.83 Mn
Dec 31, 2023 18.74 Mn
Sep 30, 2023 -17.40 Mn
Jun 30, 2023 13.85 Mn
Mar 31, 2023 3.60 Mn
API Access

Entrada Therapeutics, Inc. Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=TRDA&period=max&api_key=YOUR_API_KEY